MindMaze Therapeutics has named healthtech veteran Zach Henderson as its new CEO, signaling a strategic shift toward aggressive global commercialization. Henderson, formerly of Glooko, succeeds founder Tej Tadi as the neurotech unicorn seeks to expand its digital rehabilitation platform across international markets.
MindMaze Therapeutics has appointed digital health veteran Zach Henderson as its new Chief Executive Officer to lead the company's transition into a global commercial-stage entity. Henderson brings extensive experience from Glooko and Welldoc to accelerate the adoption of MindMaze’s neuro-rehabilitation platform.
MindMaze Therapeutics has appointed healthtech veteran Zach Henderson as its new CEO, signaling a pivot from research-heavy development to aggressive global commercialization. Henderson will lead the digital neurotherapeutics unicorn as it seeks to scale its VR-based brain repair platforms across international healthcare systems.